1-3 of 3
Andrew Boyd, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Recombinant Antibody to EphA3 for the Treatment of Hematologic Malignancies: Research Update and Interim Phase 1 Study Results

Anne Hagey, M.D., Jeffrey E. Lancet, MD, Varghese Palath, PhD, Andrew H Wei, MBBS, PhD, Martin Lackmann, PhD, Jorge E. Cortes, Andrew Boyd, MD, PhD, Dan Shochat, PhD, Geoffrey Yarranton, PhD, Christopher Bebbington, DPhil., Jonathan A. Leff, MD
Journal: Blood
Blood (2011) 118 (21): 4893.
https://doi.org/10.1182/blood.V118.21.4893.4893
Published: 2011
Journal Articles

A Recombinant Antibody to EphA3 with Pro-Apoptotic and Enhanced ADCC Activity Against Various Hematologic Malignancies Shows Selective Inhibition of Colony Formation From Long-Term Culture-Initiating Cells (LTC-ICs) In Primary Leukemia Samples

Varghese Palath, PhD, Rohini Vekhande, Mark Baer, PhD, Wendy Ching, PhD, Nenad Tomasevic, PhD, David Martinez, Christina Yi, Swathi Bhaskar, Kenneth Luehrsen, Jason Williams, John Leung, Alan F. List, MD, Ling Zhang, MD, Martin Lackmann, PhD, Andrew Boyd, MD, PhD, Andrew Scott, PhD, Daniela Cilloni, MD, PhD, Geoffrey Yarranton, PhD, Christopher Bebbington, DPhil.
Journal: Blood
Blood (2010) 116 (21): 2897.
https://doi.org/10.1182/blood.V116.21.2897.2897
Published: 2010
Journal Articles

A Recombinant Human Antibody to EphA3 with Pro-Apoptotic and Enhanced ADCC Activity Shows Selective Cytotoxicity against Myeloid Leukemia Cells and CD123-Positive Leukemic Stem Cells.

Varghese Palath, PhD, Rohini Vekhande, Andreia Lee, Jason Williams, Ling Zhang, MD, Alan F List, MD, Andrew Boyd, MD, PhD, Martin Lackmann, PhD, Andrew M Scott, PhD, Daniela Cilloni, MD, PhD, Geoffrey T. Yarranton, PhD, Christopher Bebbington, DPhil
Journal: Blood
Blood (2009) 114 (22): 1728.
https://doi.org/10.1182/blood.V114.22.1728.1728
Published: 2009